Prescription Advisory’s Vision & Values

Prescription Advisory's Vision and Values

Prescription Advisory’s Vision

Our vision is to become the gold standard for controlled substance safety and compliance.

Prescription Advisory’s Values

  • Protect patients first.
  • Obey the law.
  • Do all we can to help one another succeed.
  • Support diversity.
  • Balance work and home life.
  • Be very serious about our work, without being somber, stressed or agitated.

Prescription Advisory’s Mission

Prescription Advisory will build, operate, sell and support extraordinarily high-quality decision support tools for medical professionals who prescribe controlled substances.

Prescription Advisory’s Purpose

  • Allow prescribers to treat patients who need controlled substances, without fear of adverse consequences.
  • Help them get patients suffering from addiction into treatment.
  • Reduce the number of overdose injuries and deaths among their patients.

.

PDMPs have many limitations in their current format, including complex access issues, timeliness, and whether the data are presented to the physician automatically or require physician effort to retrieve.

ACEP - Annals of Emergency Medicine – 525

Follow Prescription Advisory

A study was conducted to estimate the societal costs of prescription opioid abuse, dependence, and misuse in the United States. Costs were grouped into three categories: health care, workplace, and criminal justice.

The results: Total US societal costs of prescription opioid abuse were estimated at $55.7 billion in 2007 (USD in 2009). Workplace costs accounted for $25.6 billion, health care costs accounted for $25.0 billion, and criminal justice costs accounted for $5.1 billion. Workplace costs were driven by lost earnings from premature death ($11.2 billion) and reduced compensation/lost employment ($7.9 billion).

Conclusions: The costs of prescription opioid abuse represent a substantial and growing economic burden for the society. The increasing prevalence of abuse suggests an even greater societal burden in the future.

Pain Medicine, Volume 12, Issue 4, April 2011
Prescription Advisory Systems & Technology

Request a PastRx Demo

We will contact you to arrange a demo at your convenience.

You have Successfully Subscribed!

Prescription Advisory Systems & Technology

Contact PastRx

A representive will be in touch to answer any questions or concerns you might have.

Thank you! A Prescription Advisory representative will contact you shortly.

Share This